Search for: "Beecham v. State"
Results 141 - 160
of 277
Sorted by Relevance
|
Sort by Date
23 Feb 2011, 2:00 am
Smithkline Beecham Corp., [855 S.W.2d 248 (Tex. [read post]
21 Jun 2011, 2:51 am
SmithKline Beecham Corp., 596 F.3d 387, 390 (7th Cir.2010). [read post]
16 Mar 2015, 10:41 am
SmithKline Beecham Corp., 567 U. [read post]
1 Jul 2017, 7:24 pm
Porter v. [read post]
6 Dec 2006, 8:43 pm
SmithKline Beecham, the Federal Circuit stated that a prior art reference need not show utility in order to be anticipatory:Under Rasmusson, the effectiveness of the prior art is not relevant . . . . [read post]
24 Mar 2019, 9:46 am
Hayes v. [read post]
8 May 2012, 6:31 pm
AND see also SmithKline Beecham Corp. v. [read post]
15 Jun 2012, 9:52 am
United States v. [read post]
13 Jun 2011, 12:10 pm
SmithKline Beecham Corp., 639 F. [read post]
6 May 2016, 5:20 am
SmithKline Beecham Corp. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
19 Jun 2012, 12:50 pm
With the Supreme Court decision yesterday in Christopher v. [read post]
27 Dec 2007, 7:09 am
SmithKline Beecham Corp., 2007 WL 2726259 (S.D. [read post]
13 Feb 2014, 9:01 pm
In Part One of this series, we began to analyze the recent decision from the federal Ninth Circuit Court of Appeals in SmithKline Beecham Corp. v. [read post]
22 May 2014, 5:00 am
Touhy v. [read post]
11 Jun 2013, 10:50 am
V. [read post]
19 Apr 2018, 11:37 pm
The question thus posed to the CPVO was whether state funding could have an impact on the grant of a compulsory license. [read post]
26 Aug 2009, 6:12 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Nexavar (Sorafenib) – India: Delhi High Court rejects Bayer complaint for patent linkage (Intellectual Property Watch) (Spicy IP) (GenericsWeb) Evista / Xigris - US: CAFC grants en banc request to challenge written description requirement: Ariad v Lilly (Patently-O) (Filewrapper) (Washington State Patent Law Blog)… [read post]
6 Jul 2012, 5:00 am
In FCC v. [read post]
15 Oct 2021, 9:43 am
Smithkline Beecham Corp. [read post]
